A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Michigan Rogel Cancer Center
Thomas Jefferson University
University of California, San Diego
St. Petersburg State Pavlov Medical University
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
University of Nebraska
University of Nebraska
Memorial Sloan Kettering Cancer Center
Mesoblast, Ltd.
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Loyola University
Fred Hutchinson Cancer Center
Jonsson Comprehensive Cancer Center
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
Dana-Farber Cancer Institute
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
Emory University
Massachusetts General Hospital
Thomas Jefferson University
Massachusetts General Hospital
Affiliated Hospital to Academy of Military Medical Sciences
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
The Korean Society of Blood and Marrow Transplantation
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Northwestern University
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center